Multiclonality of ER Expression in DCIS: Implications & Future Research | Oncotarget



August 1, 2023

  • Share
  • Oncotarget published this editorial on July 20, 2023 in Volume 14, entitled, “Multiclonality of ER expression in DCIS – Implications for clinical practice and future research” by Dr. Mangesh A. Thorat from the Breast Services, Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom; Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom. DOI - Correspondence to - Mangesh A. Thorat -; Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Oncotarget - Keywords - cancer, ductal carcinoma in situ (DCIS), invasive breast cancer, ER, recurrence, clonality About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit and connect with us: SoundCloud - Facebook - Twitter - Instagram - YouTube - LinkedIn - Pinterest - Reddit - Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer Research

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.